TrialNature metabolism2024

A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.

Murielle M Véniant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.